Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo

被引:60
作者
Juul, K
Nielsen, LB
Munkholm, K
Stender, S
Nordestgaard, BG
机构
[1] UNIV COPENHAGEN, DEPT CLIN BIOCHEM, HERLEV HOSP, DK-2730 HERLEV, DENMARK
[2] ODENSE UNIV, INST CLIN, ODENSE, DENMARK
关键词
atherosclerosis; lipoproteins;
D O I
10.1161/01.CIR.94.7.1698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of the present study was to investigate whether oxidized LDL (ox-LDL) in the arterial intima could be derived from LDL already oxidized in plasma. Methods and Results Rabbits received an intravenous injection of I-125-labeled normal LDL (N-LDL) mixed with I-131-labeled : LDL that had been mildly oxidized through exposure to Cu2+. The aortic accumulation of undegraded labeled LDL was expressed as plasma equivalents and calculated as radioactivity in the intima/inner media (cpm/cm(2)) divided by the time-averaged concentration of radioactivity in plasma (cpm/nL): for the thoracic aorta, the accumulation of undegraded ox-LDL in the intima/inner media exceeded that of undegraded N-LDL by 286% (n=6, P<.04), 863% (n=7, P<.02), and 364% (n=8, P<.01) after 1, 3, and 24 hours of exposure, respectively. There was a strong positive association between the extent of oxidation and the excess accumulation of undegraded ox-LDL compared with N-LDL (thoracic aorta; 3 hours of exposure: r=.97, n=14, P<.00001). To measure degradation of N-LDL and ox-LDL, I-125-LDL labeled with I-131-tyramine cellobiose was injected intravenously 24 hours before: the aortic intima/inner media was removed: for the thoracic aorta, the accumulation of degradation products from ox-LDL (n=6) exceeded that from N-LDL (n=6) by 301% (P<.04). Conclusions The present data suggest a novel mechanism: mildly oxidized LDL may circulate in plasma for a period sufficiently long to enter, accumulate, and be degraded in the arterial intima in preference to N-LDL.
引用
收藏
页码:1698 / 1704
页数:7
相关论文
共 39 条
  • [1] PRESENCE OF A MODIFIED LOW-DENSITY LIPOPROTEIN IN HUMANS
    AVOGARO, P
    BON, GB
    CAZZOLATO, G
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 79 - 87
  • [2] ENDOTHELIAL TRANSPORT OF ANIONIZED AND CATIONIZED FERRITIN IN THE RABBIT THORACIC AORTA AND VASA VASORUM
    BALDWIN, AL
    CHIEN, S
    [J]. ARTERIOSCLEROSIS, 1984, 4 (04): : 372 - 382
  • [3] METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS
    BILHEIMER, DW
    LEVY, RI
    EISENBERG, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) : 212 - +
  • [4] MEASUREMENT INVIVO OF IRREVERSIBLE DEGRADATION OF LOW-DENSITY LIPOPROTEIN IN THE RABBIT AORTA - PREDOMINANCE OF INTIMAL DEGRADATION
    CAREW, TE
    PITTMAN, RC
    MARCHAND, ER
    STEINBERG, D
    [J]. ARTERIOSCLEROSIS, 1984, 4 (03): : 214 - 224
  • [5] LOW-DENSITY-LIPOPROTEIN MODIFICATION AND ARTERIAL-WALL ACCUMULATION IN A RABBIT MODEL OF ATHEROSCLEROSIS
    CHANG, MY
    LEES, AM
    LEES, RS
    [J]. BIOCHEMISTRY, 1993, 32 (33) : 8518 - 8524
  • [6] LIPOPROTEIN OXIDATION AND CYTO-TOXICITY - EFFECT OF PROBUCOL ON STREPTOZOTOCIN-TREATED RATS
    CHISOLM, GM
    MOREL, DW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (03) : B20 - B26
  • [7] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN
    ESTERBAUER, H
    STRIEGL, G
    PUHL, H
    ROTHENEDER, M
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01): : 67 - 75
  • [8] ENHANCED MACROPHAGE DEGRADATION OF BIOLOGICALLY MODIFIED LOW-DENSITY LIPOPROTEIN
    HENRIKSEN, T
    MAHONEY, EM
    STEINBERG, D
    [J]. ARTERIOSCLEROSIS, 1983, 3 (02): : 149 - 159
  • [9] HODIS HN, 1994, J LIPID RES, V35, P669
  • [10] KIM MJ, 1994, ATHEROSCLEROSIS, V108, P5